Indeed, while FABP4 deficiency resulted in increased invading cells in vitro, PPAR-γ activation with rosiglitazone blocked invasion and lung metastases, increasing the survival of mice injected intrasplenically with gastric cancer cells [86]. The gene discussed is FABP4; the disease is gastric cancer.